the psychiatry world is belatedly exhibiting outrage toward a man whose ability to lure pharma cash seems to know no bounds he may be the textbook case of a key opinion leader of course , i speak of charles bling bling nemeroff rather than list the many questionable at best behaviors he has exhibited , each of which has called into question his standing as a scientist as opposed to a blatant drug marketer , i just want to a direct everyone to a detailed list of his speaking engagements from glaxosmithkline and b discuss a month of living the high life , nemeroff style as is well known by now , , nemeroff appears to have not been particularly forthcoming about the huge amounts he was making while moonlighting for every drug company on the planet see below despite requirements that he do so according to psychiatrist danny carlat from to , gsk paid nemeroff a total of , note that this was not research grant money , or money for emory 's psychiatry department these were fees that went into his personal bank account , which he earned by either sitting on gsk 's advisory board , or speaking to doctors about gsk products his typical fee for a talk was plus expenses , but sometimes he made more of this , , the total amount he disclosed to emory his employer , to whom he was required to report such income was , according to a gsk document hosted by senator charles grassley , nemeroff took in over grand in one month from speaking engagements for gsk not bad work if you can get it , eh ? and this month does n't seem unusual for nemeroff these are only his speeches for gsk he also gave speeches for several other companies the document goes on and on pages of paid speech listings , nearly all of them featuring nemeroff i just picked to because they were on the first pages of the document , which covers expenses from to for dr bling bling nemeroff gsk honoraria from march , to april , date speaking fee includes some 'expenses' i suspect was the speaking fee total , probably , excluding travel expenses imagine making k in a month for basically reading slides a few times that were quite possibly entirely written by a drug company and many of these talks were accompanied by posh meals , the kind that myself and most of my readers might eat once or twice a year here 's a nemeroff disclosure from a recent journal article dr nemeroff has received grants from or performed research for the american foundation for suicide prevention , astrazeneca , bristol myers squibb , forest laboratories , inc , janssen pharmaceutica , narsad themental health research association , the national institute of mental health , pfizer pharmaceuticals , and wyeth ayerst laboratories has been a consultant to abbott laboratories , acadia pharmaceuticals , bristol myers squibb , corcept therapeutics , cypress bioscience , cyberonics , eli lilly and co , entrepreneur s fund , forest laboratories , inc , glaxosmithkline , i dln , janssen pharmaceutica , lundbeck , otsuka america pharmaceutical , inc , pfizer pharmaceuticals , quintiles transnational , ucb pharma , and wyeth ayerst laboratories has been on the speakers bureau for abbott laboratories , glaxosmithkline , janssen pharmaceutica , and pfizer pharmaceuticals is a stockholder in acadia pharmaceuticals , corcept therapeutics , cypress bioscience , and novadel pharma inc is on the board of directors of the american foundation for suicide prevention , the american psychiatric institute for research and education , the george west mental health foundation , novadel pharma inc , and the national foundation for mental health holds patents on a method and devices for transdermal delivery of lithium us , , b and on a method to estimate serotonin and norepinephrine transporter occupancy after drug treatment using patient or animal serum provisional filing april and holds equity in reevax , bmc jr llc , and cenerx no , i did n't make that up as ed silverman wrote at pharmalot , it also raises a question when he did find time to do anything else ?